YPF Sociedad Anónima Announces Fourth Amendment to Exchange Offers and Consent Solicitation
News provided by
Share this article
YPF or the
Company ) today announced its decision to amend the terms and conditions of its amended and restated Exchange Offer and Consent Solicitation Memorandum dated January 25, 2021, as amended on February 1, 2021 (the
Exchange Offer and Consent Solicitation Memorandum ). Capitalized terms used herein and not otherwise defined shall have the meaning ascribed to them in the Exchange Offer and Consent Solicitation Memorandum.
YPF has continued to engage throughout this process in good faith discussions with Eligible Holders of all of its Old Notes seeking to adjust the terms of its exchange offers taking into consideration applicable regulations. On February 7, 2021, the Board of Directors of YPF received a letter and expression of support from Eligible Holders of the Company s 8.500% Senior Notes due 2021 (the
EU arrogance goes far beyond vaccine fiasco
We can t make the EU play fair if we continue to play nice. We have to focus on our strengths, focus on the world outside the EU, and forge our own destiny like the confident and outward looking nation we are
Ursula Von Delusion On 5 February 2021 11:54 After more than a week of the EU’s attempted brinkmanship and sheer incompetence over their vaccine rollout programme, it all culminated in the EU trying to tear up the Good Friday Agreement and block the export of vaccines. This was done without any conversations with Member States - including Ireland – but this is just the tip of the iceberg and it is easy to recall all the other vindictive actions taken by the EU against the UK over the past few days – as well as over the last few years.
Savaria (Sweden) AB: Undertaking to accept Savaria (Sweden) s recommended offer for Handicare obtained for 62.9 per cent of the shares
Stephen Reitknecht
Nicolas Rimbert
Important information
Savaria (Sweden) discloses the information provided herein pursuant to the Swedish Stock Market (Takeover Bids) Act and the Takeover Rules. The information was submitted for announcement at 08:45 (CET) on 4 February 2021.
This press release has been published in Swedish and English. In the event of any discrepancy in content between the two language versions, the Swedish version shall prevail.
The Offer is not being made, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Switzerland or the United States or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law, by use of mail or any other communication means or instrumentality (including, without
Important information
Savaria (Sweden) discloses the information provided herein pursuant to the Swedish Stock Market (Takeover Bids) Act and the Takeover Rules. The information was submitted for announcement at 08:45 (CET) on 4 February 2021.
This press release has been published in Swedish and English. In the event of any discrepancy in content between the two language versions, the Swedish version shall prevail.
The Offer is not being made, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Switzerland or the United States or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law, by use of mail or any other communication means or instrumentality (including, without limitation, facsimile transmission, electronic mail, telex, telephone and the Internet) of interstate or foreign commerce, or of any facility of national securities exchange
Roar BidCo s outstanding public offer for Recipharm AB (publ) - Consent granted to correct error in the Convertible Bond Terms
On 14 December 2020, EQT IX
1
2
( Roar BidCo ), announced a public offer to the shareholders and holders of the Senior Unsecured Convertible Bonds (the Convertible Bonds ) ( Holders of Convertible Bonds ) in Recipharm AB (publ) ( Recipharm or the Company ) to tender all their shares
3 and Convertible Bonds to Roar BidCo (the Offer ). An offer document relating to the Offer was made public on 17 December 2020 (the Offer Document ). The Offer was subsequently increased on 28 January 2021 (the Revised Offer ). A supplement to the Offer Document was registered with the Swedish Financial Supervisory Authority on 1 February 2021 (the Supplement ).